retatrutide clinical data retatrutide (LY-3437943) Market Analysis, 2033: Triple-Agonist Therapy Landscape In Obesity And Metabolic Disorders ADA 2026: Retatrutide Revolution

See what other BA editors think of the taste Instagram content How can Grns support your health

A recent poll among older adults found that 63 percent of people ages 50 to 80 who say they are overweight are interested in taking prescription weight loss medications

No single intervention is sufficient on its own

Satiety increases

A role for a protein kinase B, LKB1, and AMPactivated protein kinase cascade

The FDAs prior warnings regarding the potential elevated risk of medullary thyroid carcinoma associated with GLP-1 RAs may encourage more patients on GLP-1 RA therapy to undergo thyroid ultrasounds, thereby enhancing tumor detection